InSightec Ltd - Product Pipeline Analysis, 2026 Update
Description
Summary Insightec Ltd (Insightec) is a healthcare company creating the next generation of patient care by realizing the therapeutic power of focused ultrasound. The company’s Exablate Prime platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease. Insightec's solutions are utilized by healthcare professionals and treatment centers to offer patients an alternative to medication-refractory conditions. The company collaborates with various treatment centers and healthcare providers to distribute its technology. InSightec is headquartered in Tirat Carmel, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InSightec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
39 Pages
- InSightec Ltd Company Overview
- InSightec Ltd Company Snapshot
- InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
- InSightec Ltd – Pipeline Analysis Overview
- InSightec Ltd - Key Facts
- InSightec Ltd - Major Products and Services
- InSightec Ltd Pipeline Products by Development Stage
- InSightec Ltd Ongoing Clinical Trials by Trial Status
- InSightec Ltd Pipeline Products Overview
- ExAblate - Brain Cancer
- ExAblate - Brain Cancer Product Overview
- ExAblate - Brain Cancer Clinical Trial
- ExAblate - Liver Cancer
- ExAblate - Liver Cancer Product Overview
- ExAblate - Metastatic Breast Cancer
- ExAblate - Metastatic Breast Cancer Product Overview
- Exablate Neuro - Alzheimer’s Disease
- Exablate Neuro - Alzheimer’s Disease Product Overview
- Exablate Neuro - Alzheimer’s Disease Clinical Trial
- Exablate Neuro System - NSCLC
- Exablate Neuro System - NSCLC Product Overview
- InSightec Ltd - Key Competitors
- InSightec Ltd - Key Employees
- InSightec Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- InSightec Ltd, Recent Developments
- Mar 03, 2026: Insightec Announces National Reimbursement in France for Mr-Guided Focused Ultrasound to Treat Essential Tremor
- Feb 05, 2026: Insightec Secures Health Canada Approval for Exablate Prime System
- Oct 16, 2025: New Ultrasound Research Tool Deployed Against Alzheimer’s, Parkinson’s
- Sep 16, 2025: Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
- Jul 08, 2025: Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson’s Disease
- Feb 24, 2025: Allina Health Neuroscience, Spine and Pain Institute Launches Focused Ultrasound Program
- Nov 22, 2024: EmStop completes trial of embolic protection system
- Apr 16, 2024: Insightec Announces Exablate Prime Availability in Europe -The Next Generation of MR-Guided Focused Ultrasound
- Mar 04, 2024: Insightec’s Groundbreaking Transcranial Mr-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
- Mar 04, 2024: Insightec’s MRgFUS secures reimbursement boost in Germany
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
- InSightec Ltd Pipeline Products by Equipment Type
- InSightec Ltd Pipeline Products by Indication
- InSightec Ltd Ongoing Clinical Trials by Trial Status
- InSightec Ltd, Key Facts
- InSightec Ltd, Major Products and Services
- InSightec Ltd Number of Pipeline Products by Development Stage
- InSightec Ltd Pipeline Products Summary by Development Stage
- InSightec Ltd Ongoing Clinical Trials by Trial Status
- InSightec Ltd Ongoing Clinical Trials Summary
- ExAblate - Brain Cancer - Product Status
- ExAblate - Brain Cancer - Product Description
- ExAblate - Brain Cancer - A Safety and Feasibility Study to Evaluate Blood Brain Barrier Disruption Using Exablate MR Guided Focused Ultrasound in Combination With Doxorubicin in Treating Pediatric Patients with Diffuse Intrinsic Pontine Gliomas (DIPG)
- ExAblate - Liver Cancer - Product Status
- ExAblate - Liver Cancer - Product Description
- ExAblate - Metastatic Breast Cancer - Product Status
- ExAblate - Metastatic Breast Cancer - Product Description
- Exablate Neuro - Alzheimer’s Disease - Product Status
- Exablate Neuro - Alzheimer’s Disease - Product Description
- Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
- Exablate Neuro - Alzheimer’s Disease - Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Exablate Neuro System - NSCLC - Product Status
- Exablate Neuro System - NSCLC - Product Description
- InSightec Ltd, Key Employees
- InSightec Ltd, Other Locations
- Glossary
- List of Figures
- InSightec Ltd Pipeline Products by Equipment Type
- InSightec Ltd Pipeline Products by Development Stage
- InSightec Ltd Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
